Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc. financial statements

Calidi Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 19.91M10-K
Cash and equivalentsUSD 5.6M10-Q
Total debtUSD 600K10-Q

Calidi Biotherapeutics, Inc. financials on 6ix · Calidi Biotherapeutics, Inc. on 6ix